Stock Analysis on Net
Stock Analysis on Net

Gilead Sciences Inc. (NASDAQ:GILD)

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

Gilead Sciences Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

Microsoft Excel
Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Accounts payable 1.15 1.21 1.38 1.04 1.31 1.41 1.66 1.00 1.10 0.89 0.94 1.00 1.01 1.43 0.98 0.90 0.92 1.04 0.87 0.89 0.84
Accrued rebates 7.32 7.35 8.42 7.56 7.42 6.60 7.54 7.32 7.57 6.12 5.95 5.61 5.62 5.51 5.87 5.60 5.47 4.77 5.02 4.84 4.99
Current portion of long-term debt, net 2.33 4.76 4.79 5.04 4.97 3.08 3.32 3.38 6.51 2.89 2.87 6.48 3.69 3.60 3.63 1.62 1.62 2.23 3.74 3.33 3.35
Other current liabilities 6.04 6.70 6.41 6.44 8.18 9.26 8.98 8.42 7.93 8.26 9.38 9.32 6.69 7.25 6.18 6.55 5.55 9.04 5.64 5.96 5.20
Current liabilities 16.84% 20.01% 21.01% 20.08% 21.87% 20.35% 21.50% 20.12% 23.12% 18.16% 19.15% 22.40% 17.01% 17.79% 16.66% 14.67% 13.57% 17.09% 15.27% 15.02% 14.38%
Long-term debt, net, excluding current portion 37.07 37.49 37.82 39.73 39.24 42.20 39.32 40.20 38.24 37.33 37.18 34.02 37.10 36.34 36.69 40.07 39.92 37.05 37.52 41.06 41.35
Long-term income taxes payable 1.63 1.52 1.48 1.54 1.45 1.41 1.43 1.38 3.49 3.28 3.35 4.19 6.10 6.20 6.37 6.18 7.60 7.02 6.92 6.76 7.44
Deferred tax liability 0.70 0.68 1.02 1.17 1.26 1.23 1.46 1.69 1.66 2.56 3.18 3.38 3.88 4.23 4.85 5.35 5.84 6.41 6.86 6.43 6.61
Other long-term obligations 2.13 1.97 2.02 2.32 2.37 2.20 2.56 2.64 2.48 2.06 1.48 2.17 2.06 1.87 1.77 1.57 1.50 1.44 1.43 1.73 2.12
Long-term liabilities 41.53% 41.67% 42.33% 44.76% 44.32% 47.03% 44.77% 45.92% 45.87% 45.22% 45.19% 43.76% 49.15% 48.64% 49.68% 53.18% 54.86% 51.92% 52.73% 55.98% 57.52%
Total liabilities 58.37% 61.68% 63.34% 64.84% 66.19% 67.38% 66.27% 66.04% 68.99% 63.38% 64.34% 66.16% 66.16% 66.43% 66.34% 67.85% 68.43% 69.00% 68.00% 71.01% 71.90%
Preferred stock, par value $0.001 per share; none outstanding 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Common stock, par value $0.001 per share 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Additional paid-in capital 16.53 15.13 14.83 15.02 14.42 13.05 13.44 13.11 12.10 10.46 10.07 9.64 9.36 8.79 8.35 8.00 7.72 6.86 6.69 6.28 6.06
Accumulated other comprehensive income (loss) 0.14 0.07 0.06 -0.03 0.16 0.22 0.13 0.17 0.12 0.05 0.05 0.02 -0.03 0.00 0.16 0.14 0.12 0.12 0.11 0.06 0.06
Retained earnings 25.11 23.26 21.91 20.32 19.37 19.49 20.31 20.84 18.93 26.24 25.66 24.29 24.60 24.83 25.19 24.04 23.76 24.02 25.19 22.64 21.96
Total Gilead stockholders’ equity 41.78% 38.46% 36.80% 35.31% 33.95% 32.77% 33.88% 34.12% 31.16% 36.75% 35.78% 33.94% 33.93% 33.62% 33.70% 32.19% 31.59% 31.01% 32.00% 28.98% 28.08%
Noncontrolling interest -0.15 -0.14 -0.14 -0.15 -0.15 -0.14 -0.16 -0.16 -0.15 -0.14 -0.12 -0.10 -0.09 -0.05 -0.04 -0.03 -0.02 -0.01 0.00 0.01 0.02
Total stockholders’ equity 41.63% 38.32% 36.66% 35.16% 33.81% 32.62% 33.73% 33.96% 31.01% 36.62% 35.66% 33.84% 33.84% 33.57% 33.66% 32.15% 31.57% 31.00% 32.00% 28.99% 28.10%
Total liabilities and stockholders’ equity 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).

The capital structure exhibits a progressive shift from a liability-centric model toward an increased reliance on stockholders' equity. Total liabilities decreased from 71.90% in March 2021 to 58.37% by March 2026, while total stockholders' equity expanded from 28.10% to 41.63% over the same period, indicating a strengthening of the solvency position and a reduction in relative leverage.

Current Liability Trends
Current liabilities experienced a period of growth, peaking at 23.12% in March 2023 before moderating to 16.84% by March 2026. Within this category, accrued rebates showed a significant upward trend, rising from approximately 5% in early 2021 to a peak of 8.42% in September 2025, suggesting an increase in relative obligations related to product rebates. Other current liabilities also remained elevated relative to baseline levels, fluctuating between 5.20% and 9.38%.
Long-Term Obligation Analysis
Long-term liabilities decreased from 57.52% to 41.53% of the total balance sheet. Long-term debt, net, remained the most significant component of the liability structure, maintaining a relatively stable range between 34.02% and 42.20%. The overall decline in long-term liabilities was primarily driven by a substantial reduction in tax-related obligations; long-term income taxes payable dropped from 7.44% to 1.63%, and deferred tax liabilities contracted sharply from 6.61% to 0.70%.
Equity Composition and Growth
The growth in stockholders' equity was characterized by a steady increase in additional paid-in capital, which rose from 6.06% in March 2021 to 16.53% by March 2026. Retained earnings demonstrated some volatility but followed a general upward trend, ending at 25.11% compared to 21.96% at the start of the period. This suggests a combination of capital injections and the retention of earnings to bolster the equity base.
Overall Financial Stability
The consistent decrease in the total liability ratio, paired with the growth of the equity component, points to a deliberate deleveraging process. The contraction of deferred tax liabilities and the strategic increase in paid-in capital have shifted the balance sheet toward a more equity-funded structure, reducing the company's relative dependence on external debt and tax-deferred obligations.

AI Ask an analyst for more